T2 Pharma

T2 Pharma Pty Ltd is an innovative Australian pharmaceutical startup focused on acquiring and commercializing novel therapeutics and advanced drug delivery systems. In November 2023, the company secured an exclusive license from Medlab Clinical to utilize and commercialize the patented NanoCelle® drug delivery technology in various patent-unprotected global markets, including parts of Asia, Africa, and South America. NanoCelle® is a sub-micron drug delivery platform that creates water-soluble nanoparticles to enhance the absorption and bioavailability of active pharmaceutical ingredients (APIs) via oral-buccal, sublingual, or topical administration. By bypassing the gastrointestinal tract and first-pass metabolism, T2 Pharma aims to deliver optimized, patient-centric treatments for chronic and acute conditions, including pain management, nutritional deficiencies, and mental health.